Delivery Order SPE2DB20D2014-SPE2DB24FA46M
- Not listed
- This is a Delivery Order federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,268.15, is for the delivery of 4,567,363,922 units of Duloxetine HCL DR 60 mg capsules. The contract has a period of performance through February 25, 2025 and is a Firm Fixed Price contract type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of 4,562,525,346 units of Duloxetine HCL DR 60 MG capsules to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,900.93 and was awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is October 19, 2023. The contract is not designated with a set-aside requirement, indicating open competition....
- This federal contract award is for the delivery of Duloxetine HCL DR 60 MG capsules to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $5,310.82 and is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 10, 2024 and was awarded on October 9, 2024. It is not designated as a set-aside contract. AmerisourceBergen, through its extensive...
- This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of Duloxetine HCL DR 60 MG capsules, with a firm fixed price of $1,305.18 and a completion date of June 26, 2025. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,674.67 firm fixed-price delivery order is for the supply of 4,564,690 units of Duloxetine HCL DR 40 mg capsules. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award is for the delivery of 4,564,513,209 units of Duloxetine HCL DR 60 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $1,511.56, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on May 6, 2024, with a completion date of May 7, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
- This federal contract award is for the delivery of 4,566,471,827 units of Duloxetine HCL DR 40 mg capsules (30 count) to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 18, 2024, with a ceiling value of $1,067.61. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
- This federal contract award was made by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract is for the delivery of 4,568,724,581 units of Duloxetine Hydrochloride Delayed-Release 60 milligram capsules. The contract has a ceiling value of $1,397.32 and is a Firm Fixed Price Delivery Order. The award is not set-aside and was made on...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) as a Firm Fixed Price Delivery Order for the supply of Duloxetine HCl DR 40 mg capsules. The award, valued at $1,483.26, has an ultimate completion date of May 14, 2025 and is not set aside for any particular type of business. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,172.84, is for the supply of 4,567,278,594 units of Duloxetine HCL DR 60 MG capsules. The award is a Firm Fixed Price delivery order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FA46MDelivery Order
This federal contract award is for the delivery of 4,562,967,827 units of Duloxetine HCL DR 60 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $1,070.83. It is a delivery order contract with a firm fixed price pricing type. The ultimate completion date is December 4, 2023. This contract is not associated with a set-aside program. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as AmerisourceBergen. Both companies are for-profit organizations that are registered in the System for Award Management (SAM.gov). AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/1/23 |